Healthy subjects aged @-@ years ( n = @ ) and @ years ( n = @ ) were vaccinated with @ of @ investigational vaccine formulations varying in antigen quantity ( @ g to @ g of hemagglutinin ) and MF@ ( ) adjuvant ( none , half dose , or full dose ) .